RESUMO
Diabetes is a complex disease caused by the combined effects of genetic and environmental factors, which seriously affects people’s health level and living quality. As a special research tool, the twin method can be used to estimate the relative effects of genes and environment on diabetes-related traits. Moreover, compared with regular study subjects, twins have natural controls. The extended methods combined with genetic statistics and molecular biology techniques also help to analyze risk factors of diabetes and clarify the true relationship between exposure and outcome. This paper reviewed the progress of the application of the twin method to diabetes factorial studies in the past ten years at home and abroad, and summarized the advantages and limitations of the classical twin model, co-twin control studies, and genome-wide and epigenetic epidemiological studies.
RESUMO
The objective of the study is to evaluate the individual main effects and combined (or interaction) effects of Hydroxy propyl β cyclodextrin (HPβCD), poly vinyl pyrrolidone (PVP K30) and sodium lauryl sulphate (SLS) on the solubility and dissolution rate of efavirenz in a series of 23 factorial experiments. The solubility of efavirenz in eight selected fluids containing HPβCD, PVP K30 and SLS as per 23 factorial study was determined. The solubility of efavirenz was markedly enhanced by HPβCD (2.95 fold), PVP K30 (2.49 fold) and SLS (226.96 fold) individually. Combination of HPβCD with PVP K30 and SLS gave a markedly higher enhancement in the solubility of efavirenz than is possible with them individually. HPβCD in combination with PVP K30 and SLS gave respectively 4.05 and 387.63 fold increase in the solubility of efavirenz. Solid inclusion complexes of efavirenz - HPβCD were prepared with and without PVP K30 and SLS as per 23- factorial design by kneading method and were evaluated. ANOVA indicated that the individual main effects of HPβCD, PVP K30 and SLS and their combined effects in enhancing the solubility and dissolution rate (K1 )and dissolution efficiency (DE30 ) were highly significant (P < 0.01).HPβCD alone gave a 16.74 fold increase in the dissolution rate of efavirenz. HPβCD in combination with PVP K30 and SLS gave respectively 19.98 and 25.13 fold increase in the dissolution rate of efavirenz. HPβCD in combination with both PVP K30 and SLS gave highest enhancement (41.61 fold) in the dissolution rate of efavirenz. Combination of HPβCD with PVP K30 and SLS has markedly enhanced the solubility as well as dissolution rate of efavirenz than is possible with them individually. Hence a combination of HPβCD with PVP K30 and / or SLS is recommended to enhance the solubility and dissolution rate of efavirenz, a BCS class II drug.